Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal worth potentially more than $900 million. Immusoft’s… Read More
More than 20 years ago, Claudia Mitchell arrived in Paris to pursue a doctorate degree in molecular biology — with a 4-month-old baby in tow. She had no close friends or… Read More
On a chilly Monday morning in January, Seattle awoke to the news that one of its most promising companies, Juno Therapeutics, reached a deal to be acquired by biotech giant… Read More